Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa

Mark Lowey
February 17, 2021

Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa's "apathetic response" as "unacceptable" and he implored the government to take initiative to establish a secure domestic vaccine supply.

... Please become a Member or login to read the rest of this article ...


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.